Patent applications and USPTO patent grants for Thomson; Christopher.The latest application filed is for "rail element for a camera slider rail system".
Patent | Date |
---|---|
Quick release camera mount Grant 11,061,302 - Thomson , et al. July 13, 2 | 2021-07-13 |
Rail Element For A Camera Slider Rail System App 20200400170 - THOMSON; Christopher ;   et al. | 2020-12-24 |
Quick Release Camera Mount App 20200050086 - THOMSON; Christopher ;   et al. | 2020-02-13 |
Autotaxin inhibitors Grant 10,183,025 - Beattie , et al. Ja | 2019-01-22 |
Chamfering Of Laminate Layers App 20180147683 - Bellanger; Yohann ;   et al. | 2018-05-31 |
Chamfering of laminate layers Grant 9,914,191 - Bellanger , et al. March 13, 2 | 2018-03-13 |
Autotaxin Inhibitors App 20180021345 - BEATTIE; David ;   et al. | 2018-01-25 |
Autotaxin inhibitors Grant 9,763,957 - Beattie , et al. September 19, 2 | 2017-09-19 |
Bicyclic heterocycle derivatives for the treatment of pulmonary arterial hypertension Grant 9,751,876 - Bruce , et al. September 5, 2 | 2017-09-05 |
Autotaxin inhibitors Grant 9,630,945 - Furminger , et al. April 25, 2 | 2017-04-25 |
Autotaxin Inhibitors App 20170037030 - Furminger; Vikki ;   et al. | 2017-02-09 |
Autotaxin inhibitors App 20170007614 - Legrand; Darren Mark ;   et al. | 2017-01-12 |
Autotaxin inhibitors Grant 9,409,895 - Legrand , et al. August 9, 2 | 2016-08-09 |
Autotaxin Inhibitors App 20160184318 - BEATTIE; David ;   et al. | 2016-06-30 |
Autotaxin Inhibitors App 20160168119 - BAETTIG; Urs ;   et al. | 2016-06-16 |
Injet Printer Maintenance Arrangement And Method App 20160009111 - LI; Ke ;   et al. | 2016-01-14 |
Autotaxin inhibitors App 20150307475 - Furminger; Vikkie ;   et al. | 2015-10-29 |
Bicyclic Heterocycle Derivatives For The Treatment Of Pulmonary Arterial Hypertension App 20150025059 - Bruce; Ian ;   et al. | 2015-01-22 |
Bicyclic heterocycle derivatives for the treatment of pulmonary arterial hypertension Grant 8,883,819 - Bruce , et al. November 11, 2 | 2014-11-11 |
Ink delivery system for inkjet printheads Grant 8,851,642 - McCallum , et al. October 7, 2 | 2014-10-07 |
Inkjet printer maintenance arrangement and method Grant 8,814,323 - Li , et al. August 26, 2 | 2014-08-26 |
Multiple print head printing apparatus and method of operation Grant 8,794,727 - Thomson , et al. August 5, 2 | 2014-08-05 |
Autotaxin inhibitors App 20140171403 - Legrand; Darren Mark ;   et al. | 2014-06-19 |
Autotaxin inhibitors App 20140171404 - FURMINGER; Vikki ;   et al. | 2014-06-19 |
3-Spirocyclic Piperidine Derivatives as Ghrelin Receptor Agonists App 20130331369 - Ambarkhane; Ameet Vijay ;   et al. | 2013-12-12 |
Injet Printer Maintenance Arrangement And Method App 20130293633 - LI; Ke ;   et al. | 2013-11-07 |
Ink Delivery System For Inkjet Printheads App 20130293640 - McCallum; Robert ;   et al. | 2013-11-07 |
3-spirocyclic piperidine derivatives as ghrelin receptor agonists Grant 8,546,416 - Ambarkhane , et al. October 1, 2 | 2013-10-01 |
Bicyclic Heterocycle Derivatives For The Treatment Of Pulmonary Arterial Hypertension App 20130237519 - Bruce; Ian ;   et al. | 2013-09-12 |
Multiple Print Head Printing Apparatus And Method Of Operation App 20130201237 - Thomson; Christopher ;   et al. | 2013-08-08 |
Chamfering Of Laminate Layers App 20130185924 - Bellanger; Yohann ;   et al. | 2013-07-25 |
3-spirocyclic Piperidine Derivatives As Ghrelin Receptor Agonists App 20120302540 - Ambarkhane; Ameet Vijay ;   et al. | 2012-11-29 |
Intestinal Gene Therapy App 20030036520 - GAULDIE, JACK ;   et al. | 2003-02-20 |
uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.
While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.
All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.